Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969).
about
Comparative in vitro activity of the new fluoroquinolone BMY-40062Comparative in vitro activity of WIN 57273, a new fluoroquinolone antimicrobial agentTrovafloxacin is active against Toxoplasma gondiiIn vitro activity of tosufloxacin, a new quinolone, against respiratory pathogens derived from cystic fibrosis sputum.In vitro activity of tosufloxacin (A-61827; T-3262) against selected genital pathogensComparative in vitro activity of a new quinolone, AM-1091E-4695, a new C-7 azetidinyl fluoronaphthyridine with enhanced activity against gram-positive and anaerobic pathogens.Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosaIn vitro evaluation of WIN 57273, a new broad-spectrum fluoroquinolone.In vitro activities of tosufloxacin, temafloxacin, and A-56620 against pathogens of diarrhea.In vitro and in vivo activities of a new quinolone, WIN 57273, possessing potent activity against gram-positive bacteria.Future directions in antimicrobial chemotherapy.WIN 57273, a new fluoroquinolone with enhanced in vitro activity versus gram-positive pathogens.In vitro activity of S-ofloxacin.Can fluoroquinolones be considered once-daily therapy?In vitro and in vivo antibacterial activities of E-4497, a new 3-amine-3-methyl-azetidinyl tricyclic fluoroquinolone.In vitro activity of sparfloxacinImpact of pH and cationic supplementation on in vitro postantibiotic effect1,8-Naphthyridine Derivatives: A Review of Multiple Biological Activities.Developments in quinolones. Bacteriology, pharmacokinetics and initial clinical experience of several investigational quinolone derivatives.In vitro emergence of quinolone-resistant mutants of Escherichia coli, Enterobacter cloacae, and Serratia marcescens.Intracellular activity of tosufloxacin (T-3262) against Salmonella enteritidis and ability to penetrate into tissue culture cells of human origin.Inhibitory effects of ciprofloxacin and sparfloxacin on DNA gyrase purified from fluoroquinolone-resistant strains of methicillin-resistant Staphylococcus aureus.In vitro evaluation of E-4695, a new fluoro-naphthyridine.In vitro activity of tosufloxacin (A-60969) and clarithromycin (A-56268, TE-031) against resistant Haemophilus influenzae, Streptococcus pneumoniae and Branhamella catarrhalis isolates.Value of new quinolones in the treatment and prophylaxis of infectious diseases: introductory remarks.
P2860
Q28329591-627BEDAA-017E-4CA8-8721-8CFB7C9DC73EQ28335923-45A843A1-396B-4C08-BA55-1D1DD8BBAE53Q28379193-0648D76A-6887-4C47-BA83-F91DD5482CB3Q34622742-FAF4F15B-C9A2-412A-A162-EAC065C20654Q34626011-7F290A6A-BBFF-4BCA-BF21-85797E16501CQ34675183-FA71979C-0BCA-47B5-AB5C-35CAFA1E27F9Q35111654-EFFE0863-0F7B-4E21-8C88-ED5A7B9732A2Q35120290-2DF9673A-A135-40AD-9A99-A7E807A4CDE3Q35248737-E7B98DBC-D8DA-4787-B1BA-C383BA9C83C9Q35249168-DB912968-C4A8-4633-969E-275C1DD87EFFQ35251994-619080A4-0A83-46CC-BBCC-596CA177680FQ35530705-7F6E0D06-CCC7-4223-BAB0-7BD67CE24E7EQ35565226-6DC27AF7-2B80-4098-95F8-85A9DC56BB43Q35566524-9A26B337-FC65-4EB2-BAC8-3FD370956553Q35661689-EA4DC32E-41AD-457B-BF04-E992F7B65D0CQ36753046-BD6C44FF-B60D-4A58-8C87-43DE4A218FF4Q36753179-732FD6A2-DBC3-4A93-9ED3-CA249AA4E07AQ36757560-33636A77-003B-4127-A7BA-DF41516E23ADQ38628084-7A0B485F-DE06-4E22-97A8-3DD97B7F5A9FQ38635746-E54965CA-339B-4243-8B56-7C79CCF7811BQ39815274-52D40400-E480-4B9F-A524-62DA774E6E5EQ39816058-E6652AD9-FD95-4A7F-AD24-D897F22BB130Q40087982-DB19FDD2-1F05-49B0-981B-AC3EC1A86146Q44130802-CAFBD75C-759A-4480-9117-F4159D7A123FQ45269526-AE964BDF-C111-44D6-BDF4-ADC8166E9B4EQ54722061-4422C8A3-6AA4-45EA-BFD2-9033740EB9FC
P2860
Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969).
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969).
@en
Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969).
@nl
type
label
Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969).
@en
Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969).
@nl
prefLabel
Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969).
@en
Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969).
@nl
P2093
P2860
P356
P1476
Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969).
@en
P2093
P2860
P304
P356
10.1128/AAC.32.5.663
P407
P577
1988-05-01T00:00:00Z